Affimed NV (AFMD) is down Tuesday morning, with the stock decreasing -3.18% in pre-market trading to 6.7. AFMD's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, AFMD ranks higher than 88% of stocks. Affimed NV has risen 1.76% over the past month, closing at $7.07 on November 2. During this period of time, the stock fell as low as $5.65 and as high as $7.35. AFMD has an average analyst recommendation of Strong Buy. The company has an average price target of $12.40.
AFMD has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on AFMD!